Bhandari Parul 4

What Happened

• Parul Bhandari, a director of NRC Health (NRC), received a grant of 7,697 restricted stock units (RSUs) on 2026-06-23. The Form 4 reports the acquisition price as $0.00 (award), so the filing shows $0 cash paid. Per the filing footnote, the award represents annual equity compensation equal to $150,000 divided by the closing stock price on the day before the company’s 2026 annual meeting.

Key Details

• Transaction date: 2026-06-23; Form 4 filed: 2026-06-25 (appears timely).
• Reported transaction: A = Award/Grant of 7,697 RSUs; filing lists $0.00 per share and $0 total (standard for grants).
• Vesting: RSUs will vest and become exercisable on the date of the issuer’s 2027 annual stockholder meeting, subject to vesting, forfeiture, and termination provisions (per footnote).
• Shares owned after transaction: Not specified in the provided filing excerpt.
• No 10b5-1, tax-withholding, or late-filing flags noted in the filing excerpt.

Context

• RSUs are a grant of future shares contingent on vesting; they are not an immediate market purchase or sale. Such grants are routine director compensation and do not by themselves indicate buying or selling sentiment. The reported $150,000 figure is the company’s stated grant value based on its plan formula, not cash paid by the insider.